Status:

UNKNOWN

Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients

Lead Sponsor:

Seoul National University Hospital

Conditions:

Proteinuria

Eligibility:

All Genders

19-70 years

Phase:

PHASE4

Brief Summary

Proteinuria is not only a marker of chronic kidney disease (CKD) progression, but also a marker of cardiovascular disease and death. In previous studies, active vitamin D deficiency is associated with...

Eligibility Criteria

Inclusion

  • Nondiabetic kidney disease patients aged 19-70 years
  • MDRD GFR ≥ 30 mL/min/1.73m2
  • Patients with residual urine protein/creatinine ratio \> 200 mg/g
  • Adequate blood pressure control as treated systolic blood pressure \<=140 or diastolic \<=90 mmHg with RAS inhibitor for more than 3 months
  • Normotensive patients untreated with RAS inhibitors
  • Serum intact PTH as 35-500 mg/dL and serum calcium less than 10.2 mg/dL
  • Patients who have not been treated vitamin D within the 3 months prior to signing the informed consent form

Exclusion

  • Patients with nephrotic-range proteinuria (24 hour urine protein \>3.5 g/24 hr)
  • Patients with rapidly progressive glomerulonephritis
  • Patients requiring renal replacement therapy immediately
  • Hypercalcemia (uncorrected serum calcium level \> 10.2 mg/dL) within 3 months
  • Malignant hypertension
  • Heart failure (New York Heart Association \[NYHA\] functional class II to IV or LVEF less than 40%)
  • Severe chronic obstructive lung disease
  • Decompensated liver disease
  • Known allergy or hypersensitivity to vitamin D
  • Current treatment with steroids and/or immunosuppressive agents
  • No other active primary malignancy requiring treatment or that limits survival to ≤ 2 years
  • History of noncompliance to medical regimen
  • Inability to give an informed consent or to cooperate with researchers (e.g., psychiatric disorder)

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT01512862

Start Date

January 1 2012

End Date

December 1 2013

Last Update

April 10 2012

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea, 463-707

2

Seoul National University Hospital

Seoul, South Korea, 110-744

3

SMG-SNU Boramae Medical Center

Seoul, South Korea, 156-707